Charadrius vociferus (killdeer)

Summary
Taxonomy ID
50402
PubChem Taxonomy
50402
Displaying entries 1 - 25 of 953 in total
Gene ID Gene Name Gene Symbol ▼ Disease Ontology
104282081 xylosyltransferase 2
  • XYLT2
104287875 xylosyltransferase 1
  • XYLT1
104288902 xylulokinase
  • XYLB
104285039 xyloside xylosyltransferase 1
  • XXYLT1
104281879 V-set domain containing T cell activation inhibitor 1
  • VTCN1
104288104 versican
  • VCAN
104286199 vascular cell adhesion molecule 1
  • VCAM1
104284701 UDP-glucuronate decarboxylase 1
  • UXS1
104284913 uronyl 2-sulfotransferase
  • UST
104295651 UDP glycosyltransferase 8
  • UGT8
104286408 UDP-glucose pyrophosphorylase 2
  • UGP2
104292531 UDP-glucose glycoprotein glucosyltransferase 2
  • UGGT2
104282332 UDP-glucose glycoprotein glucosyltransferase 1
  • UGGT1
104286361 UDP-glucose 6-dehydrogenase
  • UGDH
104290854 UDP-glucose ceramide glucosyltransferase
  • UGCG
104291094 UDP-N-acetylglucosamine pyrophosphorylase 1 like 1
  • UAP1L1
104293377 UDP-N-acetylglucosamine pyrophosphorylase 1
  • UAP1
104286449 tumor suppressor candidate 3
  • TUSC3
104290096 tyrosylprotein sulfotransferase 2
  • TPST2
104286548 tyrosylprotein sulfotransferase 1
  • TPST1
104292972 triosephosphate isomerase 1
  • TPI1
104292465 transmembrane O-mannosyltransferase targeting cadherins 4
  • TMTC4
104284295 transmembrane O-mannosyltransferase targeting cadherins 3
  • TMTC3
104284339 transmembrane O-mannosyltransferase targeting cadherins 2
  • TMTC2
104285206 transmembrane O-mannosyltransferase targeting cadherins 1
  • TMTC1

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024